Form 4: USPH CFO Hendrickson Granted 10,000 Restricted Shares

U.S. Physical Therapy's CFO, Carey P. Hendrickson, received a grant of 10,000 restricted common shares, increasing total beneficial ownership to 37,808 shares.

Summary

• Carey P. Hendrickson, Chief Financial Officer of U.S. Physical Therapy Inc. (USPH), was granted 10,000 shares of common stock as restricted stock.
• The grant was made on February 23, 2026, at a price of $0.00 per share.
• Following this transaction, Mr. Hendrickson beneficially owns a total of 37,808 shares of common stock.
• Of the total beneficial ownership, 22,796 shares are restricted stock subject to various vesting schedules through March 6, 2030.
• Vesting of these restricted shares is contingent upon Mr. Hendrickson's continued employment with the company through each applicable vesting date.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, reflecting standard executive compensation practices that align management incentives with long-term shareholder interests and promote retention.

Positives

• The grant of 10,000 restricted shares aligns the Chief Financial Officer's interests with long-term shareholder value.
• Increased beneficial ownership to 37,808 shares demonstrates continued commitment from a key executive.
• The multi-year vesting schedule encourages executive retention and sustained performance.

Negatives

• The shares are restricted and do not provide immediate liquidity or full ownership to the CFO until vesting conditions are met.
• The $0.00 acquisition price indicates a non-cash compensation event, which does not represent a direct cash investment by the officer.

Risks

• The vesting of restricted shares is contingent upon continued employment, posing a risk to the officer if employment ceases before vesting dates.
• Future share price fluctuations could impact the ultimate value of the restricted stock upon vesting.

Future Outlook

The company's compensation structure for its Chief Financial Officer includes a long-term incentive plan with restricted stock vesting through March 2030, contingent on continued employment. This indicates a strategic approach to executive retention and performance alignment over several years.

Industry Context

StockSavvy.ai notes that restricted stock grants are a common form of executive compensation in the healthcare services industry, particularly for publicly traded companies like U.S. Physical Therapy. This practice aims to align executive incentives with long-term shareholder value creation and promote retention.

Comparison to Industry Standards

• Restricted stock grants are a standard component of executive compensation packages across various industries, including healthcare, technology, and finance.
• The multi-year vesting schedule, extending to 2030, is typical for long-term incentive plans designed to retain key executives and encourage sustained performance, comparable to practices at companies like HCA Healthcare or Tenet Healthcare.
• The grant of 10,000 shares to a CFO of a company of USPH's size is within the expected range for such roles, reflecting a balance between incentive and dilution.

Stakeholder Impact

• Shareholders: The grant aligns the CFO's interests with long-term shareholder value, potentially leading to more stable and growth-oriented decision-making. However, it also represents potential future dilution as shares vest.
• Employees: The compensation structure for a key executive may set a precedent or reflect the company's overall approach to long-term incentives.
• Management: The vesting schedule provides a strong incentive for the CFO to remain with the company and contribute to its long-term success.

Next Steps

• Continued vesting of 22,796 restricted shares on various dates through March 6, 2030, contingent on continued employment.
• Ongoing beneficial ownership of 37,808 shares by the Chief Financial Officer.

Key Dates

Recommendation

This Form 4 filing reports a routine executive compensation event (restricted stock grant) and does not contain information that would fundamentally alter the investment thesis for U.S. Physical Therapy Inc. While it signals management alignment and retention, it's not a catalyst for a 'buy' or 'sell' recommendation on its own. Investors should continue to 'hold' and evaluate the company based on broader financial performance and strategic developments.

Keywords

USPH, U.S. Physical Therapy, Carey P. Hendrickson, CFO, Restricted Stock, Stock Grant, Beneficial Ownership, Executive Compensation, SEC Form 4, Insider Transaction